ENTRADA, Instituto de Investigación

IISGM Innovation:

[button-large color="red" link="/experiencias-innovacion-iisgm"]SUCCESS STORIES NEWS[/button-large]     [button-large color="red" link="/noticias-innovacion-iisgm/"]UAI NEWS[/button-large]

External innovation:

       

                                  If you have information about any innovation-related news, you can send it to us for publication at innovacion(ELIMINAR)@iisgm.com

                                                   [button-small color="green" link="https://acumbamail.com/newform/web/Gs23cI4YXUr8opI2plCnUzFlJKJm5OcURKLCO06mjghO9pyksqX/39912/"]Subscribe[/button-small]                  [button-small color="green" link="https://twitter.com/UAI_IiSGM"]Follow us[/button-small]                  [button-small color="green" link="/boletin-innovacion"]Monthly newsletter[/button-small]

[divider]

IISGM INNOVATION

[button-large color="red" link="/casos-innovacion-iisgm"]SUCCESS STORIES NEWS[/button-large]

MARAÑÓN DEVELOPS WORLD-FIRST CELL THERAPY TO PREVENT TRANSPLANT REJECTION

22 July 2021

Researchers from the Immuno–regulation Laboratory at Hospital Gregorio Marañón, responsible for this pioneering treatment based on cell therapy, presented today the results of their research, which lasted more than six years, under the direction of Rafael Correa.

This new technique using Treg cells from thymic tissue (thyTreg) aims to prevent organ rejection and ultimately eliminate the use of immunosuppressive drugs. As the patient’s own cells are used, side effects are minimal, which also improves the quality of life of the transplant recipient. This therapy could be implemented in our hospitals in the short term. More information

[button-large color="red" link="/noticias-innovacion-iisgm/"]UAI NEWS[/button-large]

UAI SATISFACTION SURVEY – 2022

28 October 2022

If you have received our services this year, we invite you to take part in our satisfaction survey to help us improve our daily practice. It is anonymous and will only take 2 minutes. Your opinion will be of great help to us. Access the survey

ISCIII’S THREE PLATFORMS SUPPORTING R&D&I IN BIOMEDICINE AND HEALTH SCIENCES HOLD THEIR ANNUAL CONFERENCE TOGETHER FOR THE FIRST TIME

From 18 to 20 October in Cádiz

The Carlos III Health Institute (ISCIII) is organising this annual meeting jointly for the first time, in a single congress held at the Palace of Congresses and Exhibitions of Cádiz.

The topics addressed at the meeting will include, among others, the convergence of the three platforms under the coordination of ISCIII; the regulation of advanced therapies; the transfer of scientific knowledge to industry and society; the development of clinical trials; opportunities to lead European research projects; the role of scientific communication; public participation in science; and the processing of patient data. Representatives of the scientific and healthcare community, ISCIII and the three Platforms, coordinated by Núria Montserrat (PNBB), Alberto Borobia (SCReN) and Lluís Blanch (ITEMAS), will take part in the conference. More information

ITEMAS OPENS ITS SUPPORT PROGRAMME FOR INNOVATIVE PROJECTS IN THE HEALTHCARE SECTOR

Open permanently

The platform for promoting and innovating the industrial capabilities of the National Health System (ITEMAS) is launching a programme to fund services aimed at innovative projects that originate in healthcare centres belonging to the National Health System (SNS) and have the potential to improve Spanish healthcare. More information